Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study
Title:
Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study
Author:
Cai, Lin Li, Linfeng Cheng, Hao Ding, Yangfeng Biao, Zhenshu Zhang, Shifa Geng, Songmei Liu, Quanzhong Fang, Hong Song, Zhiqi Lu, Yan Li, Shanshan Guo, Qing Tao, Juan He, Li Gu, Jun Yang, Qinping Han, Xiuping Gao, Xinghua Deng, Danqi Li, Shenqiu Wang, Qingyu Zhu, Jun Zhang, Jianzhong